stockrowGlucoTrack, Inc.
GCTK Healthcare Medical Devices
- EPS
- +92.1%
- Free cash flow
- +3.42%
- Total debt
- +777.8%
Quarter to June 2026, against a year earlier
Follow GCTK
Alert me
GlucoTrack, Inc. (GCTK) EV/Sales
As of 6 November 2026, GlucoTrack, Inc. (GCTK) trades at a EV/Sales of 4.2×. Over the past ten years it has ranged from −38.5× (June 2025) to 913,665,851× (November 2019); the current reading is higher than 22% of that period. That is above the Medical Devices industry median of 2.8× and above the Healthcare sector median of 3.6×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2019 | 522,885,374× | 5,520.31% |
| FY2018 | 9,303,495× | (62.71%) |
| FY2017 | 24,952,325× | (9.87%) |
| FY2016 | 27,686,110× | (78.32%) |
| FY2015 | 127,723,890× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Dec 2019 | 522,885,374× | 7.31% |
| Sep 2019 | 487,288,451× | 467.52% |
| Jun 2019 | 85,863,356× | 8.88% |
| Mar 2019 | 78,858,044× | 185.44% |
| 13 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| ICCM IceCure Medical Ltd. compare | −3.8× |
| CODX Co-Diagnostics, Inc. compare | −3.6× |
| NXL Nexalin Technology, Inc. compare | −0.1× |
| NUVOQ Holdco Nuvo Group D.G Ltd. compare | n/m |
| BJDX Bluejay Diagnostics, Inc. compare | n/m |
| DHAI DIH Holding US, Inc. compare | 0.1× |
| IVF INVO Fertility, Inc compare | 0.2× |
| GCTK GlucoTrack, Inc. | 4.2× |
| ADGM Adagio Medical Holdings, Inc. compare | 30.6× |
| Medical Devices industry median | 2.8× |
| Healthcare sector median | 3.6× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)